News

George Hanna, MD, vice president and therapeutic head of infectious diseases at Merck Laboratories, discusses data from CROI 2020 on islatravir.

The FDA approved a combination therapy of sofosbuvir and velpatasvir to treat children with hepatitis C virus.

The US government has ambitious goals to expand the number of people tested and treated for HIV in the coming years. A new study details the best interventions to make the biggest difference for the most people.

The FLU-v experimental vaccine designed to protect across influenza strains showed promising results in a recent clinical trial.

The 20vPnC pneumococcal conjugate vaccine candidate was found comparable to licensed products in safety and immunogenicity.

A new influenza vaccine, the global burden of the flu in children, and the CDC’s latest numbers on the flu disease dominates the flu update this month.

A drug known to inhibit a cellular protease TMPRSS2 could potentially be a novel therapeutic intervention for COVID-19 infections, according to German investigators who found that the cellular protein may allow entry of SARS-CoV-2 into lung cells.

The NIH has shared new information on the stability of SARS-CoV-2 virus on a variety of surfaces.

According to Abbott, the systems can run high volumes of up to 470 tests in 24 hours.

Stay on top of coronavirus developments from March 18, 2020.

An American physics teacher living in Nanjing, China shares his experience with the coronavirus outbreak response.

The FDA has issued new guidance for conducting clinical trials during the COVID-19 pandemic.

In a new study, 38% of inpatients with bacteremia at an academic medical center had low procalcitonin values.

In the midst of the ongoing COVID-19 pandemic, it’s easy to forget that the United States was already in the midst of a crisis before the virus arrived on these shores: the opioid epidemic.

Study authors provided a detailed summary of the Lombardy region of Italy’s response to the coronavirus outbreak crisis.

Results from England’s first licensed FMT stool bank are now available.

The president is urging people to limit social interactions for the next 15 days, including groups of 10 or more.

Stay on top of coronavirus developments from March 17, 2020.

The CRACKLE-2 study examined clinical characteristics of 3 CRE subsets in the US.

Coronaviruses appear to affect children less commonly and when they do, result in much more mild symptoms and are less likely to lead to severe disease.

The study followed up with 347 contacts of a coronavirus patient to see if they developed symptoms.

Many of the features of telemedicine are well-suited for helping patients with COVID-19 while minimizing the risk to health care workers.

The trial will enroll 45 health adult participants between the ages of 18 to 55 years of age over a 6-week period. The first trial participant received the investigation vaccine, mRNA-1273, today.

Stay on top of coronavirus developments from March 16, 2020.

An antibody gene delivered by a harmless virus produced anti-HIV antibodies for a sustained period.

Rifampicin should become a primary treatment options for latent tuberculosis, according to a recent study that found that safety of the drug is greater than that of isoniazid in patients without contraindication.

Sanofi and Regeneron are launching a clinical trial program which will evaluate sarilumab (Kevzara) in patients who are hospitalized with severe coronavirus (COVID-19) infection.

New Jersey residents are being instructed to remain in their homes between the hours of 8pm and 5am in attempt to control the spread of COVID-19 in the Garden State.

A mathematical model based on 4 publicly available data sets finds travel restrictions cut the rate of transmission in Wuhan, China. It also found that it likely takes several cases in a given location before the virus sparks an outbreak.

Care for critically ill coronavirus patients may include several types of treatment, but researchers don’t yet know what is the most effective.